NewLink Genetics Corp (NASDAQ:NLNK)

45.02
Delayed Data
As of 3:59pm ET
 -0.71 / -1.55%
Today’s Change
17.32
Today|||52-Week Range
58.73
+13.26%
Year-to-Date

Today’s Trading

Previous close45.73
Today’s open45.95
Day’s range43.63 - 45.97
Volume446,391
Average volume (3 months)610,107
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 07/07/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-151.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio11.7
Price/Sales7.15
Price/Book5.96

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.14-1.18%
EGRXEagle Pharmaceutical...+1.33+1.63%
EBSEmergent BioSolution...+0.24+0.73%
RGENRepligen Corp+0.35+0.84%
Data as of 4:02pm ET, 07/07/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers